Clinical Trials in Baltimore

Showing 1961-1980 of 23,476 trials

Reducing Missed Appointments

NCT06915480

There are four goals of this project: (1) To examine the impact of different appointment reminder messages on appointment attendance; (2) to determine the added benefit of a patient navigator reaching out in advance of appointments to families at elevated risk of missing their appointment, and determine the most common barriers families face in appointment attendance; (3) to evaluate which patients are at highest risk of missing their appointment, and to determine the effectiveness of the intervention trial across different patient risk levels; and (4) to examine if the missing appointment interventions increase the socioeconomic diversity patients.

Neurodevelopmental Disorders

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.5,000 participantsStarted Dec 2025

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

NCT02973789

The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, concurrent with standard therapies for stage 4 NSCLC patients, following progression while on or after platinum based treatment. The device is an experimental, portable, battery operated device for chronic administration of alternating electric fields (termed TTFields or TTF) to the region of the malignant tumor, by means of surface, insulated electrode arrays.

Nonsmall Cell Lung CancerNSCLC

NovoCure GmbH291 participantsStarted Dec 2016

Birmingham, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +121 more locations

Reducing Missed Appointments

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

Find Trials by Condition in Baltimore

Using Implementation Science to Increase Pre-Exposure Prophylaxis Uptake Among African American Women

A Long-term Safety and Efficacy Study of Danicopan as an Add-on Therapy to Complement Component 5 Inhibitor (C5i) in Participants With PNH

Evolut™ EXPAND TAVR II Pivotal Trial

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Cause of Unexplained Anaphylaxis

Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma

Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial

Vosoritide for Selected Genetic Causes of Short Stature

A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer

A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and Sarcomas

Safety and Performance Study of the FAST-FIX FLEX System for Meniscal Repairs and Meniscal Transplantations

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

Actinium Therapy for Late-stage Aggressive Sarcomas

Study of PIT565 in Relapsed and/or Refractory B-cell Malignancies

A Randomized, Active-Controlled, Double-Masked, Crossover Study to Evaluate the Clinical Performance of Deseyne (Vifilcon C) Daily Disposable Soft Contact Lens for Presbyopia Extended Depth of Focus (EDOF)

Safety and Efficacy of AON-D21 in Severe Community-Acquired Pneumonia.